• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In vitro effects of Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens on Leishmania major promastigotes.乌干达沃伯格木、点叶紫菀木和滇黔金盏苣苔对硕大利什曼原虫前鞭毛体的体外作用。
Afr J Tradit Complement Altern Med. 2010 Apr 3;7(3):264-75. doi: 10.4314/ajtcam.v7i3.54791.
2
Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major.感染硕大利什曼原虫的BALB/c小鼠对乌干达沃氏樟(Sprague)乌干达亚种(白樟科)粗提物的免疫刺激反应
Pan Afr Med J. 2014 Jan 18;17 Suppl 1(Suppl 1):15. doi: 10.11694/pamj.supp.2014.17.1.3638. eCollection 2014.
3
In vivo efficacy of oral and intraperitoneal administration of extracts of Warburgia ugandensis (Canellaceae) in experimental treatment of Old World cutaneous leishmaniasis caused by Leishmania major.乌干达沃氏樟(白樟科)提取物经口服和腹腔注射给药对硕大利什曼原虫引起的东半球皮肤利什曼病进行实验性治疗的体内疗效。
Afr J Tradit Complement Altern Med. 2009 Mar 7;6(2):207-12. doi: 10.4314/ajtcam.v6i2.57093.
4
Treating leishmaniasis in Amazonia, part 2: Multi-target evaluation of widely used plants to understand medicinal practices.亚马逊流域利什曼病的治疗方法 2:广泛使用植物的多靶点评价,以了解药用实践。
J Ethnopharmacol. 2022 May 10;289:115054. doi: 10.1016/j.jep.2022.115054. Epub 2022 Feb 5.
5
Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa.绒毛苹婆树皮甲醇提取物的抗利什曼原虫效力、毒性及植物化学成分评估
Pharm Biol. 2017 Dec;55(1):998-1009. doi: 10.1080/13880209.2017.1285946.
6
In-vitro and in-vivo comparative effects of the spring and autumn-harvested Artemisia aucheri Bioss extracts on Leishmania major.阿魏蒿春、秋季提取物对感染利什曼原虫的小白鼠体内外比较疗效
J Ethnopharmacol. 2020 Jul 15;257:112910. doi: 10.1016/j.jep.2020.112910. Epub 2020 Apr 25.
7
Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya.肯尼亚部分药用植物的抗寄生虫活性和细胞毒性
J Ethnopharmacol. 2009 Jun 25;123(3):504-9. doi: 10.1016/j.jep.2009.02.008. Epub 2009 Feb 14.
8
Infectivity of macrophages and the histopathology of cutaneous lesions, liver and spleen is attenuated by leaf extract of Vernonia amygdalina in Leishmania major infected BALB/c mice.扁桃斑鸠菊叶提取物可减轻利什曼原虫主要感染的BALB/c小鼠巨噬细胞的感染性以及皮肤病变、肝脏和脾脏的组织病理学变化。
J Complement Integr Med. 2012 Jun 18;9:Article 10. doi: 10.1515/1553-3840.1617.
9
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.抗利什曼原虫草药和植物化学物质的体外和体内抗利什曼原虫活性:2015 至 2021 年的更新。
Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579.
10
Anti-leishmanial and toxicity activities of some selected Iranian medicinal plants.一些伊朗药用植物的抗利什曼原虫和毒性活性。
Parasitol Res. 2012 Nov;111(5):2115-21. doi: 10.1007/s00436-012-3059-7. Epub 2012 Aug 9.

引用本文的文献

1
Leaf and Bark Extracts: An Alternative to Copper as Fungicide against Downy Mildew in Organic Viticulture?叶和树皮提取物:有机葡萄栽培中替代铜作为防治霜霉病杀菌剂的选择?
Plants (Basel). 2021 Dec 14;10(12):2765. doi: 10.3390/plants10122765.
2
Pharmacological Assessment of the Antiprotozoal Activity, Cytotoxicity and Genotoxicity of Medicinal Plants Used in the Treatment of Malaria in the Greater Mpigi Region in Uganda.乌干达大姆皮吉地区用于治疗疟疾的药用植物的抗原生动物活性、细胞毒性和遗传毒性的药理学评估。
Front Pharmacol. 2021 Jun 30;12:678535. doi: 10.3389/fphar.2021.678535. eCollection 2021.
3
The Anti-leishmanial Efficacy of Ethanolic Extract in Vitro and Its Effects on IFN-γ and IL-4 Response.乙醇提取物的体外抗利什曼原虫功效及其对IFN-γ和IL-4反应的影响。
Iran J Parasitol. 2017 Jul-Sep;12(3):398-407.
4
Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis.探索基于药用植物的免疫调节剂在利什曼病有效治疗中的作用。
Front Immunol. 2014 May 5;5:193. doi: 10.3389/fimmu.2014.00193. eCollection 2014.

本文引用的文献

1
Estimation of population at risk of infection and number of cases of Leishmaniasis.利什曼病感染风险人群估计及病例数
Parasitol Today. 1992 Mar;8(3):104-5. doi: 10.1016/0169-4758(92)90249-2.
2
Leishmaniasis.利什曼病
Nat Rev Microbiol. 2004 Sep;2(9):692. doi: 10.1038/nrmicro981.
3
Bioassay-guided studies on the cytotoxic and in vitro trypanocidal activities of a sesquiterpene (Muzigadial) derived from a Ugandan medicinal plant (Warburgia ugandensis).对源自乌干达药用植物(乌干达沃伯格氏樟)的倍半萜(穆齐加地尔)的细胞毒性和体外杀锥虫活性进行生物测定指导的研究。
Afr Health Sci. 2001 Aug;1(1):12-5.
4
Antileishmanial activity of a linalool-rich essential oil from Croton cajucara.来自巴西巴豆的富含芳樟醇的精油的抗利什曼原虫活性。
Antimicrob Agents Chemother. 2003 Jun;47(6):1895-901. doi: 10.1128/AAC.47.6.1895-1901.2003.
5
Vaccination against Leishmania infections.针对利什曼原虫感染的疫苗接种。
Curr Drug Targets Immune Endocr Metabol Disord. 2002 Oct;2(3):201-26. doi: 10.2174/1568008023340631.
6
Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes.一氧化氮介导的亚马逊利什曼原虫无鞭毛体中蛋白酶体依赖性寡核小体DNA片段化
Infect Immun. 2002 Jul;70(7):3727-35. doi: 10.1128/IAI.70.7.3727-3735.2002.
7
Chemotherapy of leishmaniasis.利什曼病的化疗
Curr Pharm Des. 2002;8(4):319-42. doi: 10.2174/1381612023396258.
8
Plant natural products with leishmanicidal activity.具有抗利什曼原虫活性的植物天然产物。
Nat Prod Rep. 2001 Dec;18(6):674-88. doi: 10.1039/b100455g.
9
The increase in risk factors for leishmaniasis worldwide.全球范围内利什曼病风险因素的增加。
Trans R Soc Trop Med Hyg. 2001 May-Jun;95(3):239-43. doi: 10.1016/s0035-9203(01)90223-8.
10
Evaluation of the anti-inflammatory and analgesic properties of Chasmanthera dependens leaf methanol extract.滇南兔儿风叶甲醇提取物的抗炎和镇痛特性评估。
Fitoterapia. 2001 Jun;72(5):497-502. doi: 10.1016/s0367-326x(01)00274-x.

乌干达沃伯格木、点叶紫菀木和滇黔金盏苣苔对硕大利什曼原虫前鞭毛体的体外作用。

In vitro effects of Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens on Leishmania major promastigotes.

作者信息

Githinji Edward K, Irungu Lucy W, Tonui Willy K, Rukunga Geoffrey M, Mutai Charles, Muthaura Charles N, Lugalia Reuben, Gikandi Geoffrey, Wainaina Caroline W, Ingonga Johnston M, Wanjoya Antony

机构信息

University of Nairobi, Kenya.

出版信息

Afr J Tradit Complement Altern Med. 2010 Apr 3;7(3):264-75. doi: 10.4314/ajtcam.v7i3.54791.

DOI:10.4314/ajtcam.v7i3.54791
PMID:21461155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3025625/
Abstract

Plant extracts from Warburgia ugandensis Sprague (Family: Canellaceae), Psiadia punctulata Vatke (Family: Compositae) and Chasmanthera dependens Hoschst (Family: Menispermaceae) were tested for activity on Leishmania major promastigotes (Strain IDU/KE/83 = NLB-144) and infected macrophages in vitro. Plants were collected from Baringo district, dried, extracted, weighed and tested for antileishmanial activity. Serial dilutions of the crude extracts were assayed for their activity against Leishmania major in cell free cultures and in infected macrophages in vitro. Inhibitory concentrations and levels of cytotoxicity were determined. Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens had an IC(50) of 1.114 mg/ml, 2.216 mg/ml and 4.648 mg/ml, respectively. The cytotoxicity of the drugs on BALB/c peritoneal macrophage cells was insignificant as compared to the highly toxic drug of choice Pentostam(®). The supernatants from control and Leishmania infected macrophages were analyzed for their nitrite contents by Griess reaction and nitrite absorbance measured at 540 nm. Warburgia ugandensis (stem bark water extract), Chasmanthera dependens (stem bark water extract) and Psiadia punctulata (stem bark methanol extract) produced 112.3%, 94% and 88.5% more nitric oxide than the untreated infected macrophages respectively. Plant crude extracts had significant (p<0.05) anti-leishmanial and immunomodulative effects but insignificant cytotoxic effects at 1mg/ml concentration. All experiments were performed in triplicate. Statistical analysis of the differences between mean values obtained from the experimental group compared to the controls was done by students't test. ANOVA was used to determine the differences between the various treatment groups. The analysis program Probit was used to determine IC(50)s.

摘要

对来自乌干达沃氏樟(樟科)、点叶刺冠菊(菊科)和依赖南美防己(防己科)的植物提取物进行了体外抗硕大利什曼原虫前鞭毛体(菌株IDU/KE/83 = NLB - 144)及感染巨噬细胞活性的测试。植物采自巴林戈区,经干燥、提取、称重后进行抗利什曼活性测试。对粗提物进行系列稀释,测定其在无细胞培养体系及体外感染巨噬细胞中对硕大利什曼原虫的活性。测定抑制浓度及细胞毒性水平。乌干达沃氏樟、点叶刺冠菊和依赖南美防己的半数抑制浓度(IC50)分别为1.114 mg/ml、2.216 mg/ml和4.648 mg/ml。与高毒性的首选药物喷他脒相比,这些药物对BALB/c腹膜巨噬细胞的细胞毒性不显著。通过格里斯反应分析对照及利什曼原虫感染巨噬细胞的上清液中亚硝酸盐含量,并在540 nm处测定亚硝酸盐吸光度。乌干达沃氏樟(茎皮水提取物)、依赖南美防己(茎皮水提取物)和点叶刺冠菊(茎皮甲醇提取物)分别比未处理的感染巨噬细胞产生多112.3%、94%和88.5%的一氧化氮。植物粗提物在1mg/ml浓度时具有显著(p<0.05)的抗利什曼及免疫调节作用,但细胞毒性不显著。所有实验均重复三次。通过学生t检验对实验组与对照组所得平均值之间的差异进行统计分析。采用方差分析确定各治疗组之间的差异。使用概率分析程序确定IC50值。